The Bfast [SARS-CoV-2] RT-PCR kit in 48 reaction wells format from BforCure has just been marked CE-IVD*!
This in vitro diagnostic kit is now ready to be marketed throughout the European Union and used by medical laboratories with automated tools, dedicated to high volumes and important flows of PCR analyses for the diagnosis of COVID-19.
BforCure's R&D teams have optimised the protocol and reaction volume in the kit specifically for laboratories that process large numbers of samples in an automated and standardised manner. The kit allows them to improve test reproducibility by minimising human error and delivering reliable results quickly for maximum efficiency.
The Bfast [SARS-CoV-2] RT-PCR - 48 kit detects all current SARS-CoV-2 variants, including Omicron and Delta, which are currently under special scrutiny.
*CE marking guarantees that a product meets the essential requirements of Directive 98/79/EC, which has been in force since 7 December 2003. This regulatory framework sets out the safety, performance and reliability rules with which manufacturers must comply in order to sell their product in the European Union.